Good afternoon!

Although I rarely see biotech industry RIM topics discussed here, I am hoping there are lots of lurkers!

This question is related to the maintaining the integrity of your GLP study data and ensuring everything is transferred to the archive at the close of the study. What processes do you have in place to comply with 40 CFR part 160.33, 21 CFR part 58.33, and OECD GLP 1997 1.2.2 (i)?

Feel free to contact me offline, since I'm sure this applies to so few.

Thanks so much!

Cherise Forbes
Sr. Global Archivist
678/638-3658



--------------------------------------------------------
This e-mail and any files transmitted with it are confidential and
intended solely for the use of the individual or entity to whom they
are addressed. If you have received this e-mail in error please notify
the system manager: [log in to unmask] This e-mail and its
attachments have been scanned for the presence of computer
viruses, however it is always advisable to run a virus check on
e-mails and attachments before opening them.
--------------------------------------------------------

List archives at http://lists.ufl.edu/archives/recmgmt-l.html
Contact [log in to unmask] for assistance
To unsubscribe from this list, click the below link. If not already present, place UNSUBSCRIBE RECMGMT-L or UNSUB RECMGMT-L in the body of the message.
mailto:[log in to unmask]